Study2018

Single Ultra-High-Dose Cholecalciferol to Prevent Vitamin D Deficiency in Pediatric Hematopoietic Stem Cell Transplantation

Wallace G, Jodele S, Myers KC, Dandoy CE, El-Bietar J, Nelson A, Teusink-Cross A, Khandelwal P, Taggart C, Gordon CM, Davies SM, Howell JC

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 23 citations

Review labels

Funding not disclosed

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
Controlled clinical trial (classified by our AI screen)
Studied in
People
Main outcome
Health markers and function

Who paid for it

Funding
Funding not disclosed

Publication

Published
2018-05-18 · Biol Blood Marrow Transplant · vol. 24 · issue 9 · pp. 1856–1860
Publisher
Elsevier BV
Cited
28 citations · more than 88% of similar papers · 2.3× the field average
References
15 works
Access
Open access (hybrid journal) · CC-BY-NC-ND
Research areas
Vitamin D Research Studies · Pharmacological Effects and Toxicity Studies · Pregnancy and Medication Impact
Keywords
Medicine, Vitamin D and neurology, Transplantation, Hematopoietic stem cell transplantation, Mucositis, vitamin D deficiency, Gastroenterology, Internal medicine, Vitamin, Cholecalciferol, Surgery, Chemotherapy
MeSH
humans, vitamin d deficiency, cholecalciferol, transplantation conditioning, hematopoietic stem cell transplantation, adolescent, child, child, preschool, infant, female, male, calcium-regulating hormones and agents

12 authors

From US

  • Gregory H. WallaceCincinnati Children's Hospital Medical Center; University of Cincinnati
  • Sonata JodeleCincinnati Children's Hospital Medical Center; University of Cincinnati
  • Kasiani C. MyersCincinnati Children's Hospital Medical Center; University of Cincinnati
  • Christopher E. DandoyCincinnati Children's Hospital Medical Center; University of Cincinnati
  • Javier Amin El-BietarCincinnati Children's Hospital Medical Center; University of Cincinnati
  • Adam C. NelsonCincinnati Children's Hospital Medical Center; University of Cincinnati

Abstract

Vitamin D deficiency is prevalent among childhood hematopoietic stem cell transplantation (HSCT) recipients and associated with inferior survival at 100 days after transplantation. Achieving and maintaining therapeutic vitamin D levels in HSCT recipients is extremely challenging in the first 3 to 6 months after transplantation due to poor compliance in the setting of mucositis and the concomitant use of critical transplantation drugs that interfere with vitamin D absorption. We sought to evaluate the safety and efficacy of a single, ultra-high-dose of vitamin D given before childhood HSCT to maintain levels in a therapeutic range during the peritransplantation period. Ten HSCT recipients with pretransplantation 25-OH vitamin D (25OHD) level 30 ng/mL. Mean vitamin D levels were sustained at or above 30 ng/mL during the 8-week observation window. There were no electrolyte abnormalities attributed to the ultra-high-dose of vitamin D. Most patients had mildly elevated urine calcium/creatinine ratios during treatment, but none showed clinical or radiologic signs of nephrocalcinosis or nephrolithiasis. Our findings indicate that single ultra-high-oral dose vitamin D treatment given just before HSCT is safe and well tolerated in the immediate peritransplant period in children. Patients in our study were able to achieve and sustain therapeutic vitamin D levels throughout the critical period during which vitamin D insufficiency is associated with decreased overall survival. Larger prospective studies are needed to address the impact of single ultra-high-dose vitamin D treatment on HSCT outcomes.

Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY-NC-ND).

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.